Chemed (NYSE:CHE) EVP Spencer Lee Sells 1,000 Shares of Stock

Chemed Corporation (NYSE:CHE) EVP Spencer Lee sold 1,000 shares of the business’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $541.04, for a total transaction of $541,040.00. Following the sale, the executive vice president directly owned 13,912 shares of the company’s stock, valued at approximately $7,526,948.48. The trade was a 6.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Chemed Price Performance

Shares of NYSE CHE opened at $540.18 on Tuesday. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $557.00. The stock has a market cap of $7.06 billion, a price-to-earnings ratio of 27.13, a PEG ratio of 2.05 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. The firm’s 50-day simple moving average is $501.57 and its 200 day simple moving average is $447.26.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. The business had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The company’s quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, research analysts anticipate that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.

Chemed Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be given a dividend of $0.70 per share. The ex-dividend date of this dividend is Monday, August 17th. This is a positive change from Chemed’s previous quarterly dividend of $0.60. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. Chemed’s payout ratio is presently 14.06%.

Analyst Ratings Changes

A number of equities research analysts recently commented on CHE shares. Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Royal Bank Of Canada increased their target price on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a report on Thursday, July 30th. Finally, Oppenheimer raised their price target on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research report on Friday, July 31st. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $530.75.

Institutional Trading of Chemed

A number of institutional investors and hedge funds have recently modified their holdings of CHE. TD Asset Management Inc increased its position in shares of Chemed by 7.5% during the 4th quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock valued at $138,860,000 after purchasing an additional 22,715 shares during the last quarter. BNP Paribas Financial Markets raised its stake in shares of Chemed by 14.5% during the 4th quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock worth $14,985,000 after purchasing an additional 4,430 shares during the period. Epoch Investment Partners Inc. boosted its holdings in shares of Chemed by 4.9% in the 4th quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company’s stock worth $137,945,000 after buying an additional 15,133 shares during the last quarter. Abacus FCF Advisors LLC purchased a new position in shares of Chemed in the 4th quarter worth about $5,935,000. Finally, C WorldWide Group Holding A S bought a new position in Chemed during the fourth quarter valued at about $2,189,000. 95.85% of the stock is owned by hedge funds and other institutional investors.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.